Director/PDMR Shareholding


 

TIDMCRYO 
 
RNS Number : 0036K 
Cryo-Save Group NV 
12 April 2010 
 

12 April 2010 
 
Cryo-Save Group N.V. 
 
Director/PDMR Shareholding 
 
Cryo-Save Group N.V.(AIM/Euronext: CRYO, or 'the Group'), Europe's leading stem 
cell bank, has been informed that Mr Marc Waeterschoot, Chief Executive Officer, 
purchased 17,296 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price 
range between EUR5.66 and EUR5.70 between 7 April and 9 April 2010. 
 
Following these purchases, Marc Waeterschoot is beneficially interested in 
1,810,000 ordinary shares, representing approximately 19.60% of the Group's 
issued share capital. 
 
Enquiries: 
 
+-------------------------------------+---------------------+ 
| Cryo-Save Group                     |   +31 (0)575 548998 | 
+-------------------------------------+---------------------+ 
| Marc Waeterschoot, Chief Executive  |                     | 
| Officer                             |                     | 
+-------------------------------------+---------------------+ 
| Arnoud van Tulder, Chief Financial  |                     | 
| Officer                             |                     | 
+-------------------------------------+---------------------+ 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| Daniel Stewart & Company plc        |     +44 (0) 20 7776 | 
|                                     |                6550 | 
+-------------------------------------+---------------------+ 
| Simon Leathers/Emma Earl            |                     | 
+-------------------------------------+---------------------+ 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| College Hill (UK)                   |    + 44 (0) 20 7457 | 
|                                     |                2020 | 
+-------------------------------------+---------------------+ 
| Adrian Duffield/Rozi Morris         |                     | 
+-------------------------------------+---------------------+ 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| SPJ Financiële Communicatie         |  +31 (0)20 647 8181 | 
| Amstelveen (NL)                     |                     | 
+-------------------------------------+---------------------+ 
| Kees Jongsma/Léon Melens            |                     | 
+-------------------------------------+---------------------+ 
 
About Cryo-Save 
 
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSLLFSRSEIAIII

Cryo-Save (LSE:CRYO)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025